You are here

resTORbio to Present at 8th Annual SVB Leerink Global Healthcare Conference

BOSTON, Feb. 21, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing a new class of medicines that target the biology of aging to prevent or treat age-related diseases, today announced that company management will present a corporate overview at the 8th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 27, 2019 at 3:30 p.m. ET in New York, NY.
Thursday, February 21, 2019 - 08:00